Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

IDYA

IDEAYA Biosciences, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1676725Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.22B
Net Income FY2025
$(0.11B)
EPS (Basic, as reported)
$-1.28
Net Margin FY2025
-52.0%
ROE FY2025
-11.1%
Total Equity
$1.02B
Shares Out
96M
Business description

IDEAYA Biosciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 219
Fiscal yearFY2017FY2018FY2019FY2020⚑FY2021FY2022⚑FY2023⚑FY2024FY2025
Revenue——0202851237219
Research & development(12)(32)(34)(40)(58)(90)(130)(295)(315)
General & administrative(2)(5)(10)(15)(20)(24)(28)(39)(63)
Total operating expenses(14)(36)(44)(55)(78)(113)(158)(334)(378)
Operating income(14)(36)(44)(35)(50)(63)(134)(327)(159)
Interest & investment income022——————
Other income (expense), net222114215246
Income tax expense—00000000
Net income(12)(34)(42)(34)(50)(59)(113)(274)(114)
EPS — basic———($1.40)($1.41)($1.42)($1.96)($3.36)($1.28)
EPS — diluted———($1.40)($1.41)($1.42)($1.96)($3.36)($1.28)
Shares outstanding — basic (M)———253541588288
Shares outstanding — diluted (M)———253541588288
  • ⚑ Weighted-average shares changed ×1.40 between FY2020 and FY2021 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.41 between FY2022 and FY2023 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.41 between FY2023 and FY2024 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.